Latest Breaking News On - Areas of interest astellas pharma inc - Page 1 : comparemela.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

- Leverages Poseida s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ Astellas.

Xyphos biosciencesAstellas pharmaKristin yaremaNaoki okamuraAdam pearsonAstellas companyPoseida therapeutics incExchange commissionXyphos biosciences incAreas of interest astellas pharma incAstellas pharma incPoseida therapeuticsChimeric antigen receptorChief strategy officerPrimary focusFocus area approach

Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics

Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAstellas pharmaKevin friedmanAdam pearsonNaoki okamuraXyphos biosciencesAstellas companyPrnewswire astellas pharma incXyphos biosciences incAreas of interest astellas pharma incAstellas pharma incKelonia therapeuticsChimeric antigen receptorChief strategy officerPrimary focusFocus area approach

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Darren jiNaoki okamuraAdam pearsonElpiscience biopharma ltdAreas of interest astellas pharma incResearch collaborationAstellas pharma incAstellas enterLicense agreementNovel bispecific macrophageAstellas pharmaBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focuses

Elpiscience And Astellas Enter Into Research Collaboration And License Agreement For Novel Bispecific Macrophage Engager

Elpiscience And Astellas Enter Into Research Collaboration And License Agreement For Novel Bispecific Macrophage Engager
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Darren jiAdam pearsonNaoki okamuraAstellas pharma incAreas of interest astellas pharma incPrnewswire elpiscience biopharma ltdAstellas pharmaBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focusesFocus area approachBispecific macrophage engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager

Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Naoki okamuraDarren jiAdam pearsonAreas of interest astellas pharma incElpiscience biopharma ltdAstellas pharma incCorporate communicationsAstellas pharmaBusiness wireBispecific macrophage engager platformTumor associated macrophageTumor microenvironmentChief strategy officerPrimary focusesFocus area approachBispecific macrophage engager